McGoverne, Isabella
Dunn, Jenny
Batham, Jacob
Tu, Wen Juan
Chrisp, Jeremy
Rao, Sudha
Funding for this research was provided by:
Australian Government Research Training Program Stipend Scholarship
Article History
Received: 19 October 2019
Accepted: 7 April 2020
First Online: 21 April 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: In accordance with NHMRC guidelines and our ethical obligations as researchers, SR, WT have a financial interest in EpiAxis Therapeutics Pty Ltd. JC is also the CEO of EpiAxis Therapeutics Pty Ltd. We have in place a plan for managing any potential conflicts arising from that involvement.